Upstream Matters. Downstream Follows.
Before there was a price tag, there was a decision.
We decided, before we knew what anything would cost, that the ingredients and the testing were not negotiable. Not "we'll try to keep it clean." Not "we'll cut corners where no one will notice." No trade-off on quality, no trade-off on safety. That was the foundation, and it was decided first, before packaging, before pricing, before we knew if anyone outside our own kitchen would ever buy a bottle.
Everything else followed from that. The price didn't come from a strategy meeting about positioning. It came from the cost of refusing to compromise. We didn't choose to be expensive. We chose not to cut what mattered, and the number was just what that decision cost.
That's the order people usually get backwards. They assume a brand decides on a price point and then reverse-engineers a story to justify it. Ours went the other way. Upstream, the ingredients, the testing, the certifications, came first. Downstream, the price and everything that followed from it, came after.
What "not cutting corners" actually meant
It's easy to say a brand doesn't compromise. It's harder to say what that meant in practice, so here's what it meant in ours.
There's a simple way to think about risk, popularised by a US military leader, that shows up across strategy, medicine, and engineering, anywhere a decision has to be made without complete information. It splits what you're dealing with into three categories: things you know, things you know you don't know, and things you don't even know you don't know.
Most cleaning products only ever address the first category, the label, the fragrance, the promise of a spotless counter. That part is easy, because it's the only part most brands are ever asked about.
The second category is the one careful people quietly wonder about: is there something in here that isn't good for my skin, does this actually biodegrade, what happens if my toddler touches the floor twenty minutes after I've mopped it. Answerable questions, if someone has actually tested for the answer and told you what they found. This is why we test for heavy metals, pesticide residue, and cytotoxicity through NABL-accredited labs, why our biodegradability is verified against the OECD 301B standard, and why every ingredient on our label comes with a plain explanation of what it does.
The third category is the one that matters most, because you can't ask a question you don't know exists. Nobody wakes up worried about chelators left behind on a rinsed plate, or a floor cleaner's pH slowly etching marble over months of use, until someone tells them to ask. That gap, between what a customer knows to worry about and what actually affects their home, is where the real risk in this category quietly lives. Closing that gap was the upstream decision. It's also the reason the testing list kept growing instead of stopping at "good enough to pass."
The hardest question wasn't the customer's
Everyone expects a founder to worry about whether the market will buy the product. That's a business question, and business questions can be answered with data, with research, with enough spreadsheets that the anxiety eventually goes quiet.
The harder question was quieter and closer to home: would I buy this?
Not "will it sell." Would I actually use it. In my own house, on my own floors, with my own kid and my own dogs in the room. That question doesn't care about market research. It doesn't care about a NABL report either, not really, because by the time the report exists, you already know what went into the formula and what didn't. The report is proof for everyone else. The real test happens earlier, and it happens on you.
I couldn't rationalise my way past that one. I knew exactly what was in the bottle, what corners existed that a customer would never spot, and what it would have taken to hit a lower price by taking one. That question was harder to answer honestly than anything a customer would ever ask us, because I was the one person who couldn't be fooled by our own packaging.
Then the price came, and so did the anxiety
Once the upstream decisions were made, the price was just arithmetic. But knowing it was justified didn't make it comfortable. There's a specific kind of anxiety in launching something priced higher than what people are used to, in a category where most of the customer's trust has to be taken on faith, because they can't taste it, can't watch a lab test happen, can't verify a claim printed on a label except by trusting the brand that printed it.
I worried about being the outlier. I worried the price would read as arrogance instead of as the cost of a decision made months earlier, quietly, with no one watching.
Downstream is where you find out if you were right
We didn't launch a 5-litre size because it was a good business move. Customers started asking for it. That wasn't our idea. It was theirs, and it took a moment to understand what it meant.
A 500ml bottle is a trial. Nobody commits to five litres of something they're not sure about. A 5L container is what it looks like when someone has already decided they're not going back to what they used before, when they've stopped testing and started trusting.
I don't think of that as proof we won an argument. I think of it as the downstream finally catching up to the upstream: evidence, quiet and unplanned, for a decision we made before we had any evidence at all.
I still think about the price sometimes. I don't know if it's exactly the right number, and I'm not sure a "right number" exists in any provable sense. But I know what's in the bottle, I know what gap each test was built to close, and I know we're not going to make it cheaper by making it less than what we said it was.
Upstream matters. Downstream follows. We just try to make sure the order never gets reversed.
